ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE:IVC) (“Invacare” or the “Company”) announced today the pricing of $125 million principal amount of its Convertible Senior Subordinated Debentures due 2027 to be sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). As part of the transaction, the Company granted the initial purchasers a 30-day option to purchase up to an additional $10 million principal amount of the debentures to cover over-allotments, if any. Subject to customary conditions, the offering is expected to close on February 12, 2007.
